ArticleObesity surgery2026
Ligamentum Teres Repair of Hiatal Hernias in Patients Undergoing Laparoscopic Sleeve Gastrectomy.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastroesophageal reflux disease (GERD) is a frequent concern following sleeve gastrectomy (SG), particularly in patients with hiatal hernia (HH). While crural repair is commonly employed, recurrence and persistent symptoms remain challenges. Ligamentum teres repair (LTR) has been proposed as a biologically reinforced alternative. This study compares the clinical outcomes of SG with LTR (SG-LTR) versus those with standard crural repair (SG-C) in patients with concurrent HH repair, focusing on GERD symptom resolution, weight loss, and safety.
methodsThis retrospective comparative study included 64 patients with concurrent HH undergoing laparoscopic SG between November 2022 and April 2023. Patients were divided into two groups: SG with crural repair (SG-C, n = 32) and SG with ligamentum teres repair (SG-LTR, n = 32). GERD symptoms were assessed using the GERD-Q at baseline, 3 months, and 6 months. Postoperative weight loss, body mass index (BMI), and resolution of comorbidities were also evaluated.
resultsBaseline characteristics were comparable between groups. Significant reductions in BMI and GERD-Q scores were observed in both groups over 6 months (p < 0.001). SG-LTR achieved greater GERD-Q score improvement at 3 months (p = 0.019, 0.013) and 6 months (5.5 vs. 7.0, p = 0.019) and 6 months (4.0 vs. 6.0, p = 0.013). No intraoperative or postoperative complications were reported in either group. Operative time was slightly longer in SG-LTR but not statistically significant.
conclusionsSG-LTR is a safe and effective alternative to SG-C in patients undergoing SG with incidental HH. It provides superior short-term GERD symptom control without compromising weight loss outcomes. However, these findings should be interpreted with caution, as non-randomized allocation and surgeon preference may have introduced bias, and the absence of objective GERD measures (such as pH-impedance testing or postoperative endoscopy) limits validation of symptom-based outcomes.
Indexed as
Identifiers
41422175What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.